Graham Capital Management L.P. Purchases New Shares in Trupanion, Inc. (NASDAQ:TRUP)

Graham Capital Management L.P. bought a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 7,365 shares of the financial services provider's stock, valued at approximately $355,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Balyasny Asset Management L.P. raised its position in shares of Trupanion by 368.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares during the period. BNP Paribas Financial Markets raised its holdings in Trupanion by 170.7% in the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after purchasing an additional 212,545 shares during the period. Freestone Grove Partners LP bought a new position in shares of Trupanion during the fourth quarter worth $7,776,000. Baillie Gifford & Co. increased its holdings in shares of Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock worth $33,806,000 after acquiring an additional 147,341 shares in the last quarter. Finally, First Trust Advisors LP acquired a new position in shares of Trupanion in the fourth quarter valued at approximately $7,083,000.

Insider Activity at Trupanion

In other Trupanion news, SVP Emily Dreyer sold 14,025 shares of the business's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the sale, the senior vice president now directly owns 27,645 shares in the company, valued at $895,974.45. The trade was a 33.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at $3,728,629.76. The trade was a 1.89% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,792 shares of company stock worth $1,122,802. Insiders own 5.42% of the company's stock.

Trupanion Stock Down 1.8%

TRUP stock traded down $0.85 during trading on Tuesday, reaching $45.30. 352,040 shares of the stock were exchanged, compared to its average volume of 612,810. The firm's 50 day moving average is $38.21 and its 200 day moving average is $44.13. The firm has a market cap of $1.94 billion, a P/E ratio of -196.96, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a twelve month low of $25.90 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.02. The firm had revenue of $341.98 million for the quarter, compared to analysts' expectations of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The company's quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.16) EPS. As a group, research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on TRUP shares. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Lake Street Capital lowered their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Finally, Piper Sandler reduced their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Trupanion presently has a consensus rating of "Moderate Buy" and a consensus price target of $51.80.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.